Olema Pharmaceuticals Stock Market Value
| OLMA Stock | USD 25.00 0.07 0.28% |
| Symbol | Olema |
Olema Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Olema Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Olema Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Olema Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Olema Pharmaceuticals.
| 10/04/2025 |
| 01/02/2026 |
If you would invest 0.00 in Olema Pharmaceuticals on October 4, 2025 and sell it all today you would earn a total of 0.00 from holding Olema Pharmaceuticals or generate 0.0% return on investment in Olema Pharmaceuticals over 90 days. Olema Pharmaceuticals is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Bristol Myers, Merck, Boston Scientific, and Novo Nordisk. Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and comm... More
Olema Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Olema Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Olema Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.59 | |||
| Information Ratio | 0.131 | |||
| Maximum Drawdown | 145.73 | |||
| Value At Risk | (6.13) | |||
| Potential Upside | 12.77 |
Olema Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Olema Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Olema Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Olema Pharmaceuticals historical prices to predict the future Olema Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1044 | |||
| Jensen Alpha | 2.55 | |||
| Total Risk Alpha | 1.14 | |||
| Sortino Ratio | 0.5017 | |||
| Treynor Ratio | (0.58) |
Olema Pharmaceuticals Backtested Returns
Olema Pharmaceuticals is slightly risky given 3 months investment horizon. Olema Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13 % return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.26% are justified by taking the suggested risk. Use Olema Pharmaceuticals Semi Deviation of 3.75, risk adjusted performance of 0.1044, and Coefficient Of Variation of 744.44 to evaluate company specific risk that cannot be diversified away. Olema Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The company holds a Beta of -4.08, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Olema Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Olema Pharmaceuticals is expected to outperform it. Use Olema Pharmaceuticals standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to analyze future returns on Olema Pharmaceuticals.
Auto-correlation | -0.43 |
Modest reverse predictability
Olema Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between Olema Pharmaceuticals time series from 4th of October 2025 to 18th of November 2025 and 18th of November 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Olema Pharmaceuticals price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Olema Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.43 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 13.32 |
Olema Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Olema Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Olema Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Olema Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Olema Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Olema Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Olema Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Olema Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Olema Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Olema Pharmaceuticals Lagged Returns
When evaluating Olema Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Olema Pharmaceuticals stock have on its future price. Olema Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Olema Pharmaceuticals autocorrelation shows the relationship between Olema Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Olema Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Olema Pharmaceuticals Correlation, Olema Pharmaceuticals Volatility and Olema Pharmaceuticals Alpha and Beta module to complement your research on Olema Pharmaceuticals. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Olema Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.